105 results
424B3
MRZM
Marizyme, Inc.
16 Nov 23
Prospectus supplement
6:08am
).
Upon receiving FDA clearance for the DuraGraft product and insurance reimbursement approval on the products pursuant to section 2(b) of the Asset … plans, pricing and reimbursement, the potential to develop future product candidates, the timing and likelihood of success of the plans and objectives
424B3
MRZM
Marizyme, Inc.
24 Oct 23
Prospectus supplement
4:15pm
employment ceased on the Brooks Separation Date. Dr. Brooks will receive all wages and health insurance reimbursement for health insurance billed during
8-K
MRZM
Marizyme, Inc.
24 Oct 23
Departure of Directors or Certain Officers
9:08am
ceased on the Brooks Separation Date. Dr. Brooks will receive all wages and health insurance reimbursement for health insurance billed during the time
8-K
EX-99.1
MRZM
Marizyme, Inc.
23 Oct 23
Marizyme CEO Delivers Business Update
9:15am
reimbursement for DuraGraft™ (beginning in October 2024), and driving DuraGraft revenue in Europe and Asia. We have been successful or made progress in all
424B3
awej p8jch
17 Oct 23
Prospectus supplement
5:10pm
8-K
pbivua0
5 Sep 23
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-4.4
te8g22q ax
31 Jul 23
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
8:59am
8-K
EX-4.3
t9y8v2sirvcv8
31 Jul 23
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
8:59am
8-K
EX-10.1
ynb3ax pp3
12 Jul 23
Entry into a Material Definitive Agreement
12:00am
8-K
6pv399 1n
12 Jul 23
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
yjslj38x tsgyd8624g
5 Jun 23
Entry into a Material Definitive Agreement
4:19pm
8-K
sebfq1itd7ocvhi
18 May 23
Entry into a Material Definitive Agreement
5:29pm
8-K
EX-10.1
cskb8 yyap7p
18 May 23
Entry into a Material Definitive Agreement
5:29pm